|Datatrial develop software to improve the clinical research process and recently launched software ‘Nucleus’ in the US and Germany - the company’s first new product launch in 9 years following on from its leading clinical trial software nowEDC. TRI have a similar vision to Datatrial around visualisation and enhanced decision making with their OPRA solution. Collaborating nowEDC and OPRA on our Nucleus platform will allowing us to provide a streamlined approach to data collection and risk assessment for clinical and bioscience clients.|
IBM Clinical Development — a growing offering from IBM Watson Health — is helping to transform clinical research. With cloud-based electronic data capture (EDC) at its core, IBM Clinical Development addresses essentially all aspects of a clinical study in a unified, flexible and collaborative manner. IBM strives to reduce administrative burden on clinical centers and engage patients in their journeys toward healthy lives.